Literature DB >> 6972383

Assessment of Haemophilus influenzae type b opsonins by neutrophil chemiluminescence.

S L Kaplan, C L Umstead, E O Mason, D C Anderson, J C Parke, R D Feigin.   

Abstract

A luminol-enhancement chemiluminescence assay and a radiolabeled uptake assay were developed to assess opsonins for Haemophilus influenzae type b. Opsonins in acute and convalescent sera from 17 children with H. influenzae type b meningitis, along with pooled normal human sera, were evaluated and compared with anti-polyribosephosphate antibody concentrations. Five children had a rise in the chemiluminescence-area under the curve for convalescent compared with acute sera. Patient chemiluminescence--area-under-the-curve values were significantly (P less than 0.05) more likely to exceed 50% of normal human serum values if sera contained greater than or equal to 0.1 microgram of anti-polyribosephosphate antibody per ml. Magnesium ethylene glycol tetraacetic acid chelation and heat inactivation of patient and normal human sera significantly (P less than 0.05) reduced chemiluminescence--area-under-the-curve activity. Thus, complement appears to contribute significantly to the opsonization of H. influenzae type b in sera of children. Two of nine children had increases in opsonins as assayed by 3H-labeled H. influenzae type b uptake. After natural systemic H. influenzae type b infection, young children are unable to respond acutely with an increase in anti-polyribosephosphate antibody or serum opsonic activity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6972383      PMCID: PMC273827          DOI: 10.1128/jcm.13.3.532-539.1981

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  The chemiluminescence response and bactericidal activity of polymorphonuclear neutrophils from newborns and their mothers.

Authors:  E L Mills; T Thompson; B Björkstén; D Filipovich; P G Quie
Journal:  Pediatrics       Date:  1979-03       Impact factor: 7.124

2.  Responses of children immunized with the capsular polysaccharide of Hemophilus influenzae, type b.

Authors:  D H Smith; G Peter; D L Ingram; A L Harding; P Anderson
Journal:  Pediatrics       Date:  1973-11       Impact factor: 7.124

3.  Separation of serum bactericidal and opsonizing activities for Haemophilus influenzae type b.

Authors:  S L Newman; B Waldo; R B Johnston
Journal:  Infect Immun       Date:  1973-09       Impact factor: 3.441

4.  Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies.

Authors:  J B Robbins; J C Parke; R Schneerson; J K Whisnant
Journal:  Pediatr Res       Date:  1973-03       Impact factor: 3.756

5.  Experimental Haemophilus influenzae type b meningitis: immunological investigation of the infant rat model.

Authors:  D M Granoff; R Rockwell
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

6.  Luminol-enhanced chemiluminescence for evaluation of type III group B streptococcal opsonins in human sera.

Authors:  D C Anderson; M S Edwards; C J Baker
Journal:  J Infect Dis       Date:  1980-03       Impact factor: 5.226

7.  Immunization of humans with polyribophosphate, the capsular antigen of Hemophilus influenzae, type b.

Authors:  P Anderson; G Peter; R B Johnston; L H Wetterlow; D H Smith
Journal:  J Clin Invest       Date:  1972-01       Impact factor: 14.808

8.  Human serum activities against Hemophilus influenzae, type b.

Authors:  P Anderson; R B Johnston; D H Smith
Journal:  J Clin Invest       Date:  1972-01       Impact factor: 14.808

9.  Requirements of immunoglobulin and the classical and alternative complement pathways for phagocytosis and intracellular killing of multiple strains of Gram-negative aerobic bacilli.

Authors:  P Leist-Welsh; A B Bjornson
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

10.  Significance of noncapsular antigens in protection against experimental Haemophilus influenzae type b disease: cross-reactivity.

Authors:  R L Myerowitz; C W Norden; T A Demchak
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

View more
  5 in total

1.  Antibody to the outer membrane proteins is the dominant opsonic antibody in normal human serum against H. influenzae type b.

Authors:  S V Hetherington
Journal:  Immunology       Date:  1989-05       Impact factor: 7.397

2.  Haemophilus influenzae type b opsonins of intravenous immunoglobulins.

Authors:  S Bender; S Hetherington
Journal:  J Clin Immunol       Date:  1987-11       Impact factor: 8.317

3.  Generation of chemotactic activity in serum by Haemophilus influenzae type b.

Authors:  M F Tosi; S L Kaplan; E O Mason; G J Buffone; D C Anderson
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

4.  Effect of piliation on interactions of Haemophilus influenzae type b with human polymorphonuclear leukocytes.

Authors:  M F Tosi; D C Anderson; J Barrish; E O Mason; S L Kaplan
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

5.  Evaluation of Streptococcus pneumoniae type XIV opsonins by phagocytosis-associated chemiluminescence and a bactericidal assay.

Authors:  S E Gardner; D C Anderson; B J Webb; A E Stitzel; M S Edwards; R E Spitzer; C J Baker
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.